Your session is about to expire
← Back to Search
DANTE SPACE sequence for Intracranial Vascular Disease
N/A
Waitlist Available
Led By Mahmud Mossa-Basha, MD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
Study Summary
This trial will test whether the DANTE SPACE sequence provides more useful information for diagnosis than the standard MRI sequence. 100 participants with concern for intracranial vascular disease will be recruited and undergo the additional non-FDA approved DANTE SPACE sequence.
Eligible Conditions
- Intracranial Vascular Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Clinical Utility for Visualizing Pathology
Trial Design
1Treatment groups
Experimental Treatment
Group I: DANTE SPACE MRI SequenceExperimental Treatment1 Intervention
Participants will receive an additional DANTE SPACE sequence with their clinical MRI
Find a Location
Who is running the clinical trial?
University of North Carolina, Chapel HillLead Sponsor
1,508 Previous Clinical Trials
4,191,042 Total Patients Enrolled
Mahmud Mossa-Basha, MDPrincipal InvestigatorUniversity of North Carolina, Chapel Hill
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research experiment currently enrolling volunteers?
"Unfortunately, the clinical trial is not currently accepting new patients. Initially published on December 1st 2022 and last updated November 2nd of that year, it appears this research has temporarily ceased recruitment efforts; however, there are 133 other studies actively recruiting at present."
Answered by AI
Share this study with friends
Copy Link
Messenger